Goal of the analysis:
Ensure that older or established medical devices remain compliant, competitive, and profitable. This includes updating technical documentation, addressing regulatory changes, evaluating market demand, and planning upgrades, extensions, or phase-outs as needed.
Data required:
- Current device history file (DHF), including design documentation and manufacturing processes
- Post-market surveillance (PMS) data (complaints, adverse events, recalls)
- Sales and market share trends for the legacy device
- Regulatory requirements (for example, new standards like EU MDR/IVDR, updates to ISO 13485)
- Cost structure and profit margins for the device
- Competitor products and emerging technologies
- Customer feedback and clinical performance data
Detailed step-by-step instruction on how to conduct the analysis:
- Compile comprehensive device documentation. Gather all relevant technical files, risk management records, labeling, and quality system documents.
- Evaluate regulatory compliance status. Check if the device meets current regulations (for example, FDA updates, EU MDR). Identify gaps in documentation, labeling, or post-market requirements.
- Analyze market performance. Review sales data, competitive positioning, and customer feedback. Determine whether the device is maintaining, losing, or gaining market share.
- Assess technological relevance. Compare the device’s features and technology to newer options on the market. Evaluate if upgrades or design changes are needed to stay competitive.
- Review cost structure and profitability. Determine if manufacturing, materials, or maintenance costs have become unsustainable relative to device pricing or reimbursement levels.
- Identify opportunities for enhancements or line extensions. Explore minor updates (for example, software upgrades) or potential expansions to address new clinical indications.
- Consider discontinuation or replacement strategies. If the device is no longer viable, plan an orderly phase-out, including notifications, service support, and potential migration paths for existing customers.
- Summarize findings and develop a lifecycle plan. Outline actions for regulatory updates, product improvements, or market exit, prioritizing based on risk, cost, and strategic alignment.
Format of the output of analysis:
- A written lifecycle management plan that outlines regulatory obligations, product refresh opportunities, or discontinuation tactics
- A gap analysis table showing compliance shortfalls, market needs, and potential design improvements
- An updated risk management file reflecting any changes in intended use, technology, or market demands
- An executive summary with final recommendations and a high-level timeline
How to interpret results:
- A legacy device with strong market demand and compliance can benefit from incremental improvements, prolonging its lifecycle and maintaining revenue streams.
- Devices facing regulatory or market obstacles may require significant redesign or strategic repositioning to remain viable.
- Poor profitability, high maintenance costs, or limited growth prospects may indicate that discontinuation or replacement is the most prudent course.
Steps a company can take to improve on this measure:
- Regularly re-assess legacy devices against new regulations and standards to avoid compliance lapses or costly redesigns.
- Implement a proactive product monitoring strategy to capture real-world usage data and identify opportunities for incremental improvements.
- Cultivate strong customer relationships, gathering feedback on desired upgrades or unresolved clinical needs.
- Explore strategic partnerships or acquisitions to bring new technologies into older product lines.
- Maintain a clear roadmap that includes critical milestones for updating or phasing out products, ensuring clear communication with regulators and customers.
